Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose methylprednisolone before total knee arthroplasty
2014-003395-23Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Dec 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of methylprednisolone sodium succinate in knee osteoarthritis (OA), sponsored by Rigshospitalet. Primary endpoint: Change in isometric quadriceps muscle strength. Started Dec 2014; status: completed.
02
Drugs
methylprednisolone sodium succinate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2014-003395-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003395-23.